Inhibiting MNK1/2‐mediated phosphorylation of eIF4E at Ser209, thereby attenuating the translation of oncogenic mRNAs such as MYC and MCL‐1, ultimately suppressing tumor growth. The gene discussed is MCL1; the disease is neoplasm.